Dementia Researcher

In this podcast, host Dr Amanda Heslegrave explores the rapidly evolving field of blood-based biomarkers in dementia research. These biomarkers offer exciting potential for quicker, more accessible dementia diagnosis, raising crucial questions about clinical readiness and implementation. -- Amanda is joined by two expert guests: Dr Jay Amin, University of Southampton – A clinician specialising in dementia, researching inflammation and immune biomarkers, particularly focused on diagnostics and prognosis. Dr Mark Roskey, Quanterix – Senior VP involved in developing ultra-sensitive biomarker detection technologies crucial for dementia research. Together, they discuss current developments, practical hurdles, ethical considerations, and future prospects of blood-based biomarkers, sharing perspectives from clinical, research, and industry viewpoints. -- Topics Covered: